SENTI BIO Trademark

Trademark Overview

On Friday, August 23, 2019, a trademark application was filed for SENTI BIO with the United States Patent and Trademark Office. The USPTO has given the SENTI BIO trademark a serial number of 88589875. The federal status of this trademark filing is REGISTERED as of Tuesday, October 8, 2024. This trademark is owned by Senti Biosciences, Inc.. The SENTI BIO trademark is filed in the Pharmaceutical Products category with the following description:

Cells for medical or clinical use; genetic material for medical or clinical use; house mark for prescription pharmaceutical products for human use for treating diseases through cell therapy or gene therapy
senti bio

General Information

Serial Number88589875
Word MarkSENTI BIO
Filing DateFriday, August 23, 2019
Status700 - REGISTERED
Status DateTuesday, October 8, 2024
Registration Number7530747
Registration DateTuesday, October 8, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 21, 2020

Trademark Statements

Goods and ServicesCells for medical or clinical use; genetic material for medical or clinical use; house mark for prescription pharmaceutical products for human use for treating diseases through cell therapy or gene therapy
NOT AVAILABLE"BIO"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 6, 2019
Primary Code005
First Use Anywhere DateWednesday, May 1, 2024
First Use In Commerce DateWednesday, May 1, 2024

Trademark Owner History

Party NameSenti Biosciences, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameSenti Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameSenti Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Wednesday, November 27, 2019NON-FINAL ACTION WRITTEN
Tuesday, August 27, 2019NEW APPLICATION ENTERED
Friday, September 6, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, November 23, 2019ASSIGNED TO EXAMINER
Wednesday, November 27, 2019NON-FINAL ACTION E-MAILED
Wednesday, November 27, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 26, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 26, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 27, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 11, 2020ASSIGNED TO EXAMINER
Thursday, June 11, 2020ASSIGNED TO EXAMINER
Sunday, June 14, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 1, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 21, 2020PUBLISHED FOR OPPOSITION
Tuesday, July 21, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, August 6, 2020EXTENSION OF TIME TO OPPOSE RECEIVED
Friday, November 13, 2020TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, January 19, 2021OPPOSITION INSTITUTED NO. 999999
Wednesday, February 17, 2021ASSIGNED TO PETITION STAFF
Wednesday, February 17, 2021CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Tuesday, October 5, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, June 14, 2021ASSIGNED TO EXAMINER
Wednesday, August 25, 2021OPPOSITION TERMINATED NO. 999999
Wednesday, August 25, 2021OPPOSITION DISMISSED NO. 999999
Wednesday, August 25, 2021TTAB RELEASE CASE TO TRADEMARKS
Thursday, March 24, 2022SOU TEAS EXTENSION RECEIVED
Thursday, March 24, 2022SOU EXTENSION 1 FILED
Thursday, March 24, 2022SOU EXTENSION 1 GRANTED
Saturday, March 26, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 30, 2022SOU TEAS EXTENSION RECEIVED
Friday, September 30, 2022SOU EXTENSION 2 FILED
Friday, September 30, 2022SOU EXTENSION 2 GRANTED
Tuesday, October 4, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 21, 2023ASSIGNED TO EXAMINER
Tuesday, March 28, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, March 28, 2023SOU EXTENSION 3 FILED
Tuesday, March 28, 2023SOU EXTENSION 3 GRANTED
Thursday, March 30, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 30, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 30, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 30, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 30, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, September 14, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 12, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, September 12, 2023SOU EXTENSION 4 FILED
Tuesday, September 12, 2023SOU EXTENSION 4 GRANTED
Tuesday, March 26, 2024SOU EXTENSION 5 GRANTED
Tuesday, March 26, 2024SOU EXTENSION 5 FILED
Tuesday, March 26, 2024SOU TEAS EXTENSION RECEIVED
Friday, July 12, 2024STATEMENT OF USE PROCESSING COMPLETE
Wednesday, March 27, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 3, 2024USE AMENDMENT FILED
Monday, June 3, 2024TEAS STATEMENT OF USE RECEIVED
Wednesday, September 4, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, September 4, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, October 8, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, October 8, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Friday, July 12, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL

Related Keywords

senti clinical therapy medical diseases treating through cell gene human pharmaceutical